Are there different forms of life in the antineutrophil cytoplasmic antibody universe?

Annals of Internal Medicine

Volumn 143, Issue 9, 2005, Pages 683-685

  Hoffman, Gary S ^a,b   Langford, Carol A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

BIOPSY; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC VALUE; HISTOLOGY; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; MAINTENANCE THERAPY; MICROSCOPIC POLYANGIITIS; PATHOGENESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 27644438684     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-9-200511010-00012     Document Type: Review

References (10)

1. Sablé-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, et al. Antineutrophil cytoplasm antibodies and the Churg-Strauss syndrome. Ann Intern Med. 2005;143:632-8.
2. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005;143:621-31.
3. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998;41:1521-37. [PMID: 9751084]
4. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997; 8:314-22. [PMID: 9048352]
5. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53:743-53. [PMID: 9507222]
6. Wang G, Csernok E, de Groot K, Gross WL. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA). J Immunol Methods. 1997;208:203-11. [PMID: 9433475]
7. Lim LC, Taylor JG 3rd, Schmitz JL, Folds JD, Wilkman AS, Falk RJ, et al. Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology. Comparative evaluation of commercial indirect fluorescent antibody kits and enzyme immunoassay kits. Am J Clin Pathol. 1999;111:363-9. [PMID: 10078112]
8. Csernok E, Ahlquist D, Ullrich S, Gross WL. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology (Oxford). 2002;4l:1313-7. [PMID: 12422006]
9. De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52:2461-9. [PMID: 16052573]
10. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36-44. [PMID: 12840090]